— Know what they know.
Not Investment Advice

EMGE OTC

Emergent Health Corp
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -0.0% 1Y: +0.0% 3Y: -88.2% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $4193 mcap · Short 84% of daily vol

Balance Sheet Trends

Total Assets
$534K -32.5% ▼
5Y CAGR: -12.4%
Total Liabilities
$3M +56.0% ▲
5Y CAGR: +107.4%
Shareholders Equity
-$2M -113.0% ▼
Cash & Investments
$359K +3.3% ▲
5Y CAGR: -15.1%
Total Debt
$2M +49.4% ▲
Net Debt
$2M +49.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$227K$169K$258K$13K$25K
Short-Term Investments$0$0$0$334K$334K
Cash & ST Investments$227K$169K$258K$348K$359K
Net Receivables$0$0$0$250K$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$35K$37K
Total Current Assets$312K$250K$327K$633K$396K
Property, Plant & Equip.$0$0$0$50K$50K
Goodwill & Intangibles$0$70K$50K$106K$86K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$92K$2K$1K$2K$2K
Total Non-Current Assets$92K$72K$51K$158K$138K
Total Assets$404K$321K$379K$790K$534K
— Liabilities —
Accounts Payable$0$0$10K$184K$252K
Short-Term Debt$0$0$338K$2M$2M
Deferred Revenue$0$0-$337$0$0
Other Current Liabilities$4K$0$338$4K$152K
Total Current Liabilities$4K$0$347K$2M$3M
Long-Term Debt$0$0$0$0$2M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$2M
Total Liabilities$4K$0$347K$2M$3M
— Equity —
Common Stock$58K$58K$58K$261K$427K
Retained Earnings-$843K-$922K-$1M-$3M-$5M
Accumulated OCI-$58K$0$0-$261K-$427K
Total Stockholders Equity$311K$233K-$56K-$1M-$2M
Total Liabilities & Equity$404K$321K$379K$790K$534K
— Key Metrics —
Total Debt$0$0$338K$2M$2M
Net Debt-$227K-$169K$80K$2M$2M
Total Investments$0$0$0$334K$334K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms